A clinical trial of dextromethorphan in amyotrophic lateral sclerosis

Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Ole Gredal, Lene Werdelin, S. Bąk, Peter Brøgger Christensen, Gudrun Boysen, Michael Kristensen, Jesper Jespersen, Lisbeth Regeur, H H Hinge, Troels S. Jensen
Hōputu: Artigo
Reo:Ingarihi
I whakaputaina: 2009
Urunga tuihono:https://doi.org/10.1111/j.1600-0404.1997.tb00231.x
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!